Fennec Provides Corporate Update and Announces First Quarter 2016 Results
May 12, 2016 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 12, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development of...
Fennec Announces Sodium Thiosulfate Presentation for Prevention of Ototoxicity in Children at ASCO Meeting
April 20, 2016 22:11 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - April 20, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) (the "Company" or "Fennec"), a specialty pharmaceutical company...
Fennec Announces $5.0 Million Private Placement of Common Shares by Sigma Tau Finanziaria
April 08, 2016 07:59 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - April 8, 2016) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) (the "Company" or "Fennec"), a specialty pharmaceutical company...
Fennec Provides Corporate Update and Announces Fiscal Year Ended December 31, 2015 Financial Results
March 28, 2016 16:11 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - March 28, 2016) - Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec Announces New Chairman of the Board
December 09, 2015 06:30 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Dec. 9, 2015) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB: FENCF), a specialty pharmaceutical company focused on the development...
Fennec Provides Corporate Update and Announces Third Quarter 2015 Financial Results
November 12, 2015 07:30 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Nov. 12, 2015) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York on September 10, 2015
September 03, 2015 07:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Sept. 3, 2015) - Fennec Pharmaceuticals, Inc. (TSX:FRX)(OTCQB:FENCF), today announced that Rosty Raykov, CEO of Fennec, will present...
Fennec Provides Corporate Update and Announces Second Quarter 2015 Financial Results
August 11, 2015 17:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Aug. 11, 2015) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development...
Fennec Announces Presentation of Positive Interim Sodium Thiosulfate Phase III Safety Data at the 2015 ASCO Annual Meeting
May 31, 2015 21:00 ET
|
Fennec Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 31, 2015) - Fennec Pharmaceuticals, Inc. (TSX:FRX) (OTCQB:FENCF), announced the presentation of positive interim results from a...
Fennec to Present at the Jefferies 2015 Global Healthcare Conference
May 29, 2015 06:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 29, 2015) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) today announced that it will present at the Jefferies 2015 Global...